Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. May 26, 2021; 9(15): 3675-3679
Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3675
Figure 2
Figure 2 Hematological tumor immunophenotype. A: CD22 (+) and CD20 (+); B: CD56 (+) and CD16 (+); C: CD3 (+) and CD8 (+).